JUL 15·SEC EDGARLow
HRT FINANCIAL LP sold $373K of SHPH
HRT FINANCIAL LP sold 83,149 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at an average of $4.48 ($4.48–$4.67, $0.37M total) across 2 trades over 2026-07-13 to 2026-07-14.
StockNASDAQ · US · USDHealthcare · Drug Manufacturers - Specialty & Generic
$SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Price · $SHPHvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $SHPH in the last 7 days.
Insider · 30dAll trades →
- Buys
- $2K 1 txs
- Sells
- $373K 2 txs
HRT FINANCIAL LP3× · $370K
10b5-1 plan0%
Top stories · $SHPHMore →
JUL 13·SEC EDGAR
HRT FINANCIAL LP purchased $30K of SHPH
HRT FINANCIAL LP purchased 8,997 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at an average of $3.36 ($3.11–$3.38) across 2 trades over 2026-07-09 to 2026-07-10.
JUL 9·SEC EDGAR
HRT FINANCIAL LP sold $100K of SHPH
HRT FINANCIAL LP sold 29,111 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at an average of $3.45 ($3.33–$3.52, $0.10M total) across 2 trades over 2026-07-07 to 2026-07-08.
SHPH sentiment & insider activity
Recent SHPH coverage spans insider activity and financial news.
In the last 30 days, SHPH insiders filed 3 SEC Form 4 transactions — 1 purchase ($2K) and 2 sales ($373K). The most active reporter was HRT FINANCIAL LP with 3 filings.
What's driving SHPH
This is a disclosed insider sale by a large holder, but it is not tied to new fundamentals or a 10b5-1 plan.
The filing is a fresh insider buy by a significant holder, but the dollar size is small, so it is more of a sentiment signal than a fundamental catalyst.
This is a disclosed insider sale by a large holder, which can modestly affect near-term sentiment but does not change fundamentals by itself.
The filing is a new insider/10% owner buy, but the disclosed size is modest and lacks accompanying fundamental catalysts.
The filing signals incremental insider/large-owner accumulation, but it is a relatively small dollar amount and lacks a new fundamental catalyst.
alphai scores every news story that mentions SHPH with an AI model for sentiment and relevance, and aggregates insider trades from Shuttle Pharmaceuticals Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $SHPH
Score
HRT FINANCIAL LP sold $373K of SHPH
HRT FINANCIAL LP sold 83,149 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at an average of $4.48 ($4.48–$4.67, $0.37M total) across 2 trades over 2026-07-13 to 2026-07-14.
2 min readHRT FINANCIAL LP purchased $30K of SHPH
HRT FINANCIAL LP purchased 8,997 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at an average of $3.36 ($3.11–$3.38) across 2 trades over 2026-07-09 to 2026-07-10.
2 min readHRT FINANCIAL LP sold $100K of SHPH
HRT FINANCIAL LP sold 29,111 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at an average of $3.45 ($3.33–$3.52, $0.10M total) across 2 trades over 2026-07-07 to 2026-07-08.
1 min readHRT FINANCIAL LP purchased $28K of SHPH
HRT FINANCIAL LP purchased 7,851 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at $3.54 on 2026-07-02.
1 min readHRT FINANCIAL LP purchased $13K of SHPH
HRT FINANCIAL LP purchased 3,959 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at $3.30 on 2026-07-01.
2 min readHRT FINANCIAL LP purchased $111K of SHPH
HRT FINANCIAL LP purchased 32,591 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at an average of $3.40 ($3.23–$3.44, $0.11M total) across 2 trades over 2026-06-29 to 2026-06-30.
2 min read
A pharma company strikes Dogecoin mining deal backed by $11M PIPE
Shuttle Pharmaceuticals (SHPH) has announced a definitive merger agreement to acquire United Dogecoin, a Dogecoin mining company. The merger, supported by an $11 million PIPE financing, aims to create the world's largest publicly listed Dogecoin mining company based on global hashrate percentage. United Dogecoin plans to acquire up to 3,000 ElphaPex mining rigs, significantly expanding its mining capacity, and its CEO, Ryan Trasolini, will become co-CEO of the combined entity.
4 min read
Shuttle Executes LOI with Molecule.ai - Shuttle Pharmaceuticals (NASDAQ:SHPH)
GAITHERSBURG, Md., Oct. 10, 2025 ( GLOBE NEWSWIRE ) -- Shuttle Pharmaceuticals Holdings, Inc. ( NASDAQ:SHPH ) ( "Shuttle Pharma" or the "Company" ) , a discovery and development stage specialty pharmaceutical company, today announced the execution of a non-binding letter of Intent with ...
2 min readShuttle Executes LOI with Molecule.ai
GAITHERSBURG, Md., Oct. 10, 2025 ( GLOBE NEWSWIRE ) -- Shuttle Pharmaceuticals Holdings, Inc. ( Nasdaq: SHPH ) ( "Shuttle Pharma" or the "Company" ) , a discovery and development stage specialty pharmaceutical company, today announced the execution of a non-binding letter of Intent with ...
2 min readShuttle to Enter $3.24 Billion AI Pharmaceutical Market
GAITHERSBURG, Md., Oct. 09, 2025 ( GLOBE NEWSWIRE ) -- Shuttle Pharmaceuticals Holdings, Inc. ( Nasdaq: SHPH ) ( "Shuttle Pharma" or the "Company" ) , a discovery and development stage specialty pharmaceutical company, today announced the execution of a non-binding letter of Intent with ...
2 min read